medigraphic.com
Coordinación General de Investigación de la Facultad de Salud Pública y Nutrición y la Dirección General de Sistemas e Informática de la Universidad Autónoma de Nuevo León

2010, Number 1

<< Back Next >>

Rev Salud Publica Nutr 2010; 11 (1)

Alimentación: Su impacto sobre el sistema inmune y cáncer

Miranda-Hernández DF, Franco-Molina MA, Rivera-Morales LG, Rodríguez-Padilla C

Language: Spanish
References: 31
Page:
PDF size: 139.61 Kb.


ABSTRACT

A comprehensive system of medicine needed to treat cancer because current measures to patients with this disease are focused mainly on chemotherapy, radiotherapy and monoclonal antibodies in various types of cancer regardless of system involvement psychoneuroimmunological and nutritional and these were responsible for the control of cellular homeostasis. In this review we will study the mechanisms that link nutrition to the immune system and cancer development, as well as the mechanisms involved in generating a type of immunosuppressive cells called regulatory T cells that are related to the development and progression.


REFERENCES

  1. Burnet FM. 1957. Cancer a biological approach. Br Med J 1:841–7.

  2. Thomas L. 1959. Cellular and humoral aspects of the hypersensitive states. New York: Hoeber-Harper;.

  3. Schreiber TH and ER Podack 2009. A critical analysis of the tumour immunosurveillance controversy for 3-MCAinduced sarcomas. Br J Cancer.; 3:381-6.

  4. Aguirre JA. 2007.Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer;7:834–46.

  5. Udagawa Taturo 2008. Tumor dormancy of primary and secondary cancers. APMIS; 116: 615-628.

  6. Dunn GP, AT Bruce , H Ikeda , LJ Old and RD Schreiber 2002. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol.; 11:991-8.

  7. Alan B. and M Ngozi 2006. Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response. J. Leukoc. Biol; 79: 652-662.

  8. Markus F, A Jonathan, M Diane, B Christophe 2009. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nature Immunology; 10:689-695.

  9. Bubenik J. 2006. Depletion of Treg Cells Augments the Therapeutic Effect of Cancer Vaccines. Folia Biologica (Praha);.52: 202-204.

  10. Yasmine B. and O Guillaume 2008. Tuning microenviroments: induction of regulatory T cells by dendritic cells. Immunity; 29: 362-371.

  11. Paul A. and P Nicholas 2005. CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2. J Immunother; 28: 120–128.

  12. Idem.

  13. Idem.

  14. . Sheng X, J Hulin, K Thomas, M Sue, O Mohamed, L Bing and K Vijay 2008. Retinoic Acid Increases Foxp3+ Regulatory T Cells and Inhibits Development of Th17 Cells by Enhancing TGF-β-Driven Smad3 Signaling and Inhibiting IL-6 and IL-23 Receptor Expression. The Journal of Immunology; 181:2277 -2284

  15. Schmidt S. et al. 2004. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NFkB activation. Proc. Natl. Acad. Sci. USA; 101: 4566-4571.

  16. Idem.

  17. Bharat B and S Shishir 2004. Suppression of Nuclear Factor-kappa B Activation Pathway by Spice-Derived Phytochemicals: Reasoning for seasoning. Ann N Y Acad Sci. Dec;1030:434-41.

  18. Paolo L, M Giusy, B Fernando, F Luca, V Luigi, R Franco, M Luisa, M Mauro., et al 2008. Modulation of the anticancer immunity by natural agents: inhibition of T regulatory lymphocytegeneration by arabinoxylan in patients with locally limited or metastatic solid tumors. Cancer Therapy; 6:1011-1016.

  19. Singh S, K Natarajan, B Aggarwal 1996. Capsaicin (8-methyl-N-vanillyl-6- nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J Immunol; 157: 4412-20.

  20. Singh, S. and B. B. Aggarwal 1995. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem; 270: 24995-5000.

  21. Shishodia, S., et al. 2003. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res.; 63: 4375-83.

  22. Geng, Z., Y. Rong and B. H. Lau 1997. S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells. Free Radic Biol Med; 23: 345-50.

  23. Salminena A, M Lehtonenc, T Suuronena, K Kaarnirantad and J Huuskonen 2008. Terpenoids: natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential. Cell. Mol. Life Sci.; 65: 2979 – 2999.

  24. Idem.

  25. Ide, N. and B. H. Lau 2001. Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factorkappa b activation. J Nutr; 131: 1020S-6S.

  26. Idem.

  27. 27.. Kunnumakkara AB, S Guha, S Krishnan, et al 2007. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res.; 67:3853-61.

  28. Seung G, W Chuanwu, M Satoshi and H Chang 2009. High and low vitamin A therapies induce distinct FoxP3+ T cell subsets and effectively control intestinal inflammation. J.Gastro.. Article in Press.

  29. Abadias M, J Usall , M Anguera , C Solsona and I Viñas 2008. Microbiological quality of fresh, minimallyprocessed fruit and vegetables, and sprouts from retail establishments. Int J Food Microbiol.; 123:121-9.

  30. Toshio W, N Hikaru, T Tetsuya, Y Hirokazu, O Hirotoshi, W Kenji, T Kazunari., et al 2009. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury-Involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol. Sep;297(3):G506-13.

  31. Idem.




2020     |     www.medigraphic.com